Suppr超能文献

维持性血液透析的肾衰竭儿童的内分泌与生长异常——罗马尼亚西部单中心经验

ENDOCRINE AND GROWTH ABNORMALITIES IN CHILDREN WITH KIDNEY FAILURE ON MAINTENANCE HEMODIALYSIS - EXPERIENCE OF A SINGLE CENTER FROM WESTERN ROMANIA.

作者信息

Steflea R, Stroescu R F, Gafencu M, Chisavu F, Stoicescu E R, Doros G

机构信息

"Victor Babes" University of Medicine and Pharmacy, XI Pediatrics, Timișoara, Romania.

"Louis Turcanu" Emergency Hospital for Children - Pediatrics, Timișoara, Romania.

出版信息

Acta Endocrinol (Buchar). 2024 Jul-Sep;20(3):393-400. doi: 10.4183/aeb.2024.393. Epub 2025 May 23.

Abstract

UNLABELLED

The underlying mechanisms for endocrine disturbances in patients with kidney alterations are complex.

AIM

To provide better longitudinal follow-up of children, especially to check their progress through puberty.

MATERIAL AND METHODS

A prospective study was conducted at the "Louis Turcanu" Emergency Hospital for Children in Timisoara, Romania during 01.01.2022- 31.12.2024. The study population included ten pediatric patients with end stage renal disease (ESRD) on hemodialysis. Data were collected from the electronic medical records and included demographic information and relevant laboratory parameters, which reflect the patients' anemia status, inflammation, mineral metabolism and other endocrine abnormalities.

RESULTS

Erythropoietin doses ranged from 87 to 176 units/kg once a week at the beginning of our study, higher than guidelines recommendations. Most patients presented with hemoglobin levels below the normal range which slightly increased over the 3 years period. Vitamin D levels ranged from 8.1 to 55.8 ng/mL. These resulted in a poor control of the mineral bone disease associated with kidney failure.

CONCLUSIONS

The loss of kidney function is associated with an impaired control of phosphor-calcium balance, and anemia, growth and pubertal delay in children. This study highlights the need for individualized treatment plans and a multidisciplinary approach in pediatric patients with ESRD.

摘要

未标注

肾脏改变患者内分泌紊乱的潜在机制很复杂。

目的

为儿童提供更好的纵向随访,尤其是检查他们青春期的进展情况。

材料与方法

2022年1月1日至2024年12月31日期间,在罗马尼亚蒂米什瓦拉的“路易·图尔卡努”儿童医院进行了一项前瞻性研究。研究人群包括10名接受血液透析的终末期肾病(ESRD)儿科患者。数据从电子病历中收集,包括人口统计学信息和相关实验室参数,这些参数反映了患者的贫血状况、炎症、矿物质代谢和其他内分泌异常情况。

结果

在我们研究开始时,促红细胞生成素剂量为每周一次,范围从87至176单位/千克,高于指南推荐剂量。大多数患者的血红蛋白水平低于正常范围,在3年期间略有升高。维生素D水平范围为8.1至55.8纳克/毫升。这些导致与肾衰竭相关的矿物质骨病控制不佳。

结论

肾功能丧失与儿童磷钙平衡控制受损、贫血、生长和青春期延迟有关。本研究强调了对ESRD儿科患者制定个体化治疗方案和采用多学科方法的必要性。

相似文献

1
3
Adapting Safety Plans for Autistic Adults with Involvement from the Autism Community.
Autism Adulthood. 2025 May 28;7(3):293-302. doi: 10.1089/aut.2023.0124. eCollection 2025 Jun.
4
Aural toilet (ear cleaning) for chronic suppurative otitis media.
Cochrane Database Syst Rev. 2025 Jun 9;6(6):CD013057. doi: 10.1002/14651858.CD013057.pub3.
5
Community views on mass drug administration for soil-transmitted helminths: a qualitative evidence synthesis.
Cochrane Database Syst Rev. 2025 Jun 20;6:CD015794. doi: 10.1002/14651858.CD015794.pub2.
6
Non-pharmacological interventions for sleep promotion in hospitalized children.
Cochrane Database Syst Rev. 2022 Jun 15;6(6):CD012908. doi: 10.1002/14651858.CD012908.pub2.
9
Prognostic factors for return to work in breast cancer survivors.
Cochrane Database Syst Rev. 2025 May 7;5(5):CD015124. doi: 10.1002/14651858.CD015124.pub2.
10
Electronic cigarettes for smoking cessation.
Cochrane Database Syst Rev. 2025 Jan 29;1(1):CD010216. doi: 10.1002/14651858.CD010216.pub9.

本文引用的文献

1
ACTUALITIES IN THE MANAGEMENT OF SECONDARY HYPERPARATHYROIDISM DUE TO CHRONIC KIDNEY DISEASE IN CHILDREN.
Acta Endocrinol (Buchar). 2023 Jul-Sep;19(3):403-406. doi: 10.4183/aeb.2023.403. Epub 2024 Feb 1.
2
Endocrine manifestations of chronic kidney disease and their evolving management: A systematic review.
Dis Mon. 2022 Dec;68(12):101466. doi: 10.1016/j.disamonth.2022.101466. Epub 2022 Aug 12.
3
Use of erythropoiesis-stimulating agents in children with chronic kidney disease: a systematic review.
Clin Kidney J. 2022 Feb 26;15(8):1483-1505. doi: 10.1093/ckj/sfac058. eCollection 2022 Aug.
4
"Ideal" parathyroid hormone in erythropoietin-stimulating agents-resistant anemia.
EJHaem. 2021 Nov 24;3(1):159-162. doi: 10.1002/jha2.316. eCollection 2022 Feb.
5
Kidney disease and thyroid dysfunction: the chicken or egg problem.
Pediatr Nephrol. 2022 Dec;37(12):3031-3042. doi: 10.1007/s00467-022-05640-z. Epub 2022 Jun 23.
6
Growth Hormone and Insulin-Like Growth Factor Dysregulation in Pediatric Chronic Kidney Disease.
Horm Res Paediatr. 2021;94(3-4):105-114. doi: 10.1159/000516558. Epub 2021 Jul 13.
7
The Interplay Between Thyroid Dysfunction and Kidney Disease.
Semin Nephrol. 2021 Mar;41(2):133-143. doi: 10.1016/j.semnephrol.2021.03.008.
8
The CKiD study: overview and summary of findings related to kidney disease progression.
Pediatr Nephrol. 2021 Mar;36(3):527-538. doi: 10.1007/s00467-019-04458-6. Epub 2020 Feb 3.
9
Clinical practice recommendations for growth hormone treatment in children with chronic kidney disease.
Nat Rev Nephrol. 2019 Sep;15(9):577-589. doi: 10.1038/s41581-019-0161-4. Epub 2019 Jun 13.
10
Ergocalciferol Supplementation in Hemodialysis Patients With Vitamin D Deficiency: A Randomized Clinical Trial.
J Am Soc Nephrol. 2016 Jun;27(6):1801-10. doi: 10.1681/ASN.2015040468. Epub 2015 Dec 17.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验